Economic evaluation of novel direct acting antiviral (DAA) treatment strategies for chronic hepatitis C

Publication year: 2016

Report number: 276

Type: Health Technology Assessment (HTA)

Authors: Gerkens Sophie, Thiry Nancy, Hulstaert Frank, Robays Jo

Language: The report is available in English. The synthesis is available in English.

Keywords: Hepatitis C, Chronic, Cost-Benefit Analysis, Antiviral Agents